Subunit vaccines

Subunit vaccines are composed of protein or glycoprotein components of a pathogen that are capable of inducing a protective immune response and may be produced by conventional biochemical or recombinant DNA technologies. Recombinant subunit vaccines have distinct advantages over live attenuated and inactivated vaccines since they are efficient in inducing humoral- and cell-mediated immunological responses, and the risks associated with handling the pathogen are eliminated.

    Related Conference of Subunit vaccines

    October 18-19, 2023

    43rd Global Summit and Expo on Vaccines & Immunology

    Vienna, Austria
    November 04-05, 2023

    35th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan
    February 08-09, 2024

    International Conference on Vaccine Research

    Madrid, Spain

    Subunit vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in